CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleLevered free cash flow is $27.08M, above the global median of $18.73M
- FinancialsAltman Z-Score 5.38: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
0.83%
Annual Rate
CNY 0.07Paid unknown
Payout Ratio
140.0%High
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.94BCNY737.71M · vs all stocks (USD)
Trailing P/E
168.20xRevenue (TTM)
1.84BCNY274.72M · vs all stocks (USD)
Profit Margin
1.49%Beta
0.5630xvs all stocks
52-Week Change
45.21%vs all stocks
Forward Annual Dividend Yield
0.83%vs all stocks
Market Capitalization
4.94BCNY737.71M · vs all stocks (USD)
Enterprise Value
3.92BCNY585.25M · vs all stocks (USD)
Trailing P/E
168.20xPrice to Sales (TTM)
2.44xPrice to Book (MRQ)
1.66xEnterprise to Revenue
2.13xEnterprise to EBITDA
26.87xGross Margin
42.87%Profit Margin
1.49%Operating Margin
5.04%Return on Assets (TTM)
1.39%Return on Equity (TTM)
1.30%Revenue (TTM)
1.84BCNY274.72M · vs all stocks (USD)
Revenue per Share (TTM)
3.36CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-11.60%Gross Profit (TTM)
782.69MCNY116.88M · vs all stocks (USD)
EBITDA (TTM)
128.93MCNY19.25M · vs all stocks (USD)
Net Income (TTM)
27.40MCNY4.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-49.00%Operating Cash Flow (TTM)
175.42MCNY26.20M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
181.37MCNY27.08M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0700CNYUpdated Sep 21, 2026Forward Annual Dividend Yield
0.83%vs all stocks
Trailing Annual Dividend Rate
0.0700CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.82%vs all stocks
Payout Ratio
140.00%Minority Interest (Equity)
77.20MCNYFY2025 · Dec 31, 2025Revenue
1.95BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.07BCNYFY2025 · Dec 31, 2025Gross Profit
880.69MCNYFY2025 · Dec 31, 2025Operating Income
110.77MCNY16.54M · vs all stocks (USD)
Pre-tax Income
70.87MCNYFY2025 · Dec 31, 2025Income Tax Expense
31.04MCNYFY2025 · Dec 31, 2025Net Income
39.84MCNYFY2025 · Dec 31, 2025EBIT
80.94MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
204.76MCNYFY2025 · Dec 31, 2025Research & Development
30.24MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
585.94MCNYFY2025 · Dec 31, 2025Other Operating Expenses
27.75MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.44MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
10.07MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0700CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
546.34MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
546.34MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
39.84MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.59MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
72.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
39.36MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
594.09MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
39.84MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.45MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
8.94MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.30MCNYFY2025 · Dec 31, 2025Capital Expenditures
-33.16MCNYFY2025 · Dec 31, 2025Purchase of Investments
-330.00MCNYFY2025 · Dec 31, 2025Sale of Investments
162.87MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-200.29MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
61.88MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-70.52MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-88.22MCNYFY2025 · Dec 31, 2025Other Financing Charges
-12.27MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-109.14MCNYFY2025 · Dec 31, 2025Shares Outstanding
534.07MSharesUpdated Sep 21, 2026Float Shares
310.20MSharesUpdated Sep 21, 2026% Held by Insiders
44.13%vs all stocks
% Held by Institutions
0.69%vs all stocks
Total Cash (MRQ)
708.29MCNY105.77M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.33CNYUpdated Sep 21, 2026Total Debt (MRQ)
55.53MCNY8.29M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0234xCurrent Ratio (MRQ)
2.94xBook Value per Share (MRQ)
5.06CNYUpdated Sep 21, 2026Total Assets
3.15BCNY469.66M · vs all stocks (USD)
Total Current Assets
1.65BCNYFY2025 · Dec 31, 2025Total Liabilities
747.59MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.49BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
126.77MCNYFY2025 · Dec 31, 2025Total Current Liabilities
620.82MCNYFY2025 · Dec 31, 2025Cash
541.12MCNYFY2025 · Dec 31, 2025Cash Equivalents
52.97MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
594.09MCNYFY2025 · Dec 31, 2025Other Short-term Investments
110.40MCNYFY2025 · Dec 31, 2025Accounts Receivable
320.81MCNYFY2025 · Dec 31, 2025Inventory
197.50MCNYFY2025 · Dec 31, 2025Accounts Payable
241.90MCNYFY2025 · Dec 31, 2025Short-term Debt
108.58MCNYFY2025 · Dec 31, 2025Other Current Liabilities
143.44MCNYFY2025 · Dec 31, 2025Long-term Debt
100.91MCNYFY2025 · Dec 31, 2025Common Stock (Book)
534.07MCNYFY2025 · Dec 31, 2025Retained Earnings
705.81MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.40BCNY358.02M · vs all stocks (USD)
52-Week Low
4.33CNYUpdated Sep 21, 202652-Week High
12.77CNYUpdated Sep 21, 202652-Week Change
45.21%vs all stocks
Beta
0.5630xvs all stocks
50-Day MA
7.17CNYUpdated Sep 21, 2026200-Day MA
6.18CNYUpdated Sep 21, 2026Avg 10-Day Volume
97.09MSharesUpdated Sep 21, 2026Avg 30-Day Volume
92.68MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.0500CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.40Dividend per Share: 0.07Earnings per Share: 0.05
High gross margins eroded by operating costsNotable
Gross Margin: 0.43Profit Margin: 0.01
Financial Health
Altman Z-Score 5.38: safe zoneNotable
Altman Z-Score: 5.38
High earnings qualityNotable
Earnings Quality Score: 0.65
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Levered free cash flow is $27.08M, above the global median of $18.73MNotable
Levered free cash flow (USD): 27,083,951.039Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cytek Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
QuidelOrtho Corporation
Tier 1ProductionApproval-Gated PipelineRule
Center Laboratories, Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wave Life Sciences Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Beilu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhongzhu Healthcare Holding Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sanyou Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Knight Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Yabao Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule